A novel artificial intelligence (AI) tool has revealed how disease-linked proteins misfold into harmful structures, a key ...

A novel artificial intelligence (AI) tool has revealed how disease-linked proteins misfold into harmful structures, a key advance in understanding neurodegenerative disorders such as Alzheimer's and ...

A rousing response saw Unai Emery's men hit back through Youri Tielemans, John McGinn and Ezri Konsa to earn a 3-2 win on the night, but they fell to a 5-4 aggregate loss.

Youri Tielemans praised the Villa Park support following a 5-4 aggregate loss to PSG in the UCL quarter-finals ...

A novel artificial intelligence (AI) tool has revealed how disease-linked proteins misfold into harmful structures, a key advance in understanding ...

The month was also an opportunity to load on protein, with eggs seeing a sharp fall in prices ... rising by 10.4% on an annual basis in March. House rent, for India on an aggregate, saw tepid ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer's disease (early AD) wh ...

Boehringer Ingelheim and Cue Biopharma, Inc. (Nasdaq: CUE) today announced a strategic research collaboration and license agreement to develop and commercialize Cue Biopharma’s CUE-501 product ...

Boehringer Ingelheim and Cue Biopharma Inc. have joined forces to develop and commercialize Cue Biopharma’s CUE-501 product candidate.

Boehringer Ingelheim, Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases: Ingelheim, Germany Wednesday, April 16, 2025, 09:00 Hrs ...